Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease

Journal of Endocrinological Investigation

Volumn 34, Issue 11, 2011, Pages 831-834

  Bellastella, G ^a   Rotondi, M ^b   Pane, E ^a   Costantini, S ^c   Colella, C ^a   Calemma, R ^d   Capone, F ^c   Falorni, A ^e   Castello, G ^c   Sinisi, A A ^a   Bizzarro, A ^a   Chiovato, L ^b   Bellastella, A ^a   De Bellis, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b IRCCS   (Italy)

^c Oncological Research Center of Mercogliano   (Italy)

^d IRCCS   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Hypoadrenalism; Thyroid and adrenal autoimmunity

Indexed keywords

ADRENAL CORTEX ANTIBODY; ANTIBODY; CORTICOSTEROID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADRENAL GLAND; ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; MALE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TH1 CELL; TH2 CELL;

ADDISON DISEASE; ADULT; AGED; AUTOANTIBODIES; CHEMOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 84858025298     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7414     Document Type: Article

References (24)

1. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001, 86: 2909-22. (Pubitemid 32673441)
2. De Bellis A, Bizzarro A, Rossi R, et al. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab 1993, 76: 1002-7. (Pubitemid 23110852)
3. Laureti S, De Bellis A, Muccitelli VI, et al. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab 1998, 83: 3507-11. (Pubitemid 28500880)
4. Falorni A, Laureti S, De Bellis A, et al SIE Addison Study Group. Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab 2004, 89: 1598-604. (Pubitemid 38507908)
5. Betterle C, Volpato M, Rees Smith B, et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997, 82: 939-42. (Pubitemid 27106615)
6. Betterle C, Volpato M, Rees Smith B, et al. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab 1997, 82: 932-8. (Pubitemid 27106614)
7. Drexhage HA. Autoimmune adrenal failure. In: Autoimmune endocrinopathies. Totowa: Human Press Inc. 1999, 309-36.
8. Winqvist O, Söderbergh A, Kämpe O. The autoimmune basis of adrenocortical destruction in Addison's disease. Mol Med Today 1996, 2: 282-9. (Pubitemid 126820715)
9. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12: 121-7. (Pubitemid 30398626)
10. Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P. Role of chemokines in endocrine autoimmune diseases. Endocr Rev 2007, 28: 492-520. (Pubitemid 47236335)
11. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001, 78: 57-110. (Pubitemid 32566018)
12. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354: 610-21. (Pubitemid 43209108)
13. Roep BO, Kleijwegt FS, van Halteren AG, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 2010, 159: 338-43.
14. Rotondi M, Falomi A, De Bellis A, et al. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J Clin Endocrinol Metab 2005, 90: 2357-63. (Pubitemid 40586285)
15. González-Hernández JA, Bornstein SR, Ehrhart-Bornstein M, Geschwend JE, Adler G, Scherbaum WA. Macrophages within the human adrenal gland.Cell Tissue Res 1994, 278: 201-5. (Pubitemid 24315090)
16. Vilá LM, Molina MJ, Mayor AM, Cruz JJ, Ríos-Olivares E, Ríos Z. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol 2007, 26: 718-22. (Pubitemid 46554079)
17. Syversen SW, Goll GL, Haavardsholm EA, Bøyesen P, Lea T, Kvien TK. A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients. Arthritis Res Ther 2008, 10: R28.
18. Pfleger C, Kaas A, Hansen L, et al.; Hvidøre Study Group On Childhood Diabetes. Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes. Clin Immunol 2008, 128: 57-65.
19. Franciotta D, Martino G, Zardini E, et al. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol 2001, 115: 192-8. (Pubitemid 32245668)
20. Romagnani P, Rotondi M, Lazzeri E, et al. Expression of IP-10/CX-CL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 2002, 161: 195-206. (Pubitemid 34760785)
21. Antonelli A, Rotondi M, Fallahi P, et al. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 2004, 89: 5496-9. (Pubitemid 39518431)
22. Liu C, Papewalis C, Domberg J, Scherbaum WA, Schott M. Chemokines and autoimmune thyroid diseases. Horm Metab Res 2008, 40: 6: 361-8. (Pubitemid 351967125)
23. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002, 13: 455-81. (Pubitemid 35303816)
24. Lukacs NW, Strieter RM, Einer VM, Evanoff HL, Burdick M, Kunkel SL. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. Blood 1994, 83: 1174-8.